Skip to content
10-Q

Quarterly Report

XERIS BIOPHARMA HOLDINGS, INC. XERS

0001867096-25-000159

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 165.92M sh
Shares Diluted Q3 2025 · Sep 30, 2025 177.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 158.56M sh
Shares Diluted Q3 2025 · Sep 30, 2024 148.99M sh
Shares Diluted Q3 2025 · Sep 30, 2024 145.96M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 $8.58M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$38.96M
Long Term Debt Q3 2025 · Sep 30, 2025 $219.47M
Long Term Debt Q3 2025 · Dec 31, 2024 $217.01M
Short Term Debt Q3 2025 · Sep 30, 2025 $0
Short Term Debt Q3 2025 · Dec 31, 2024 $15.1M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $91.6M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $71.62M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $59.23M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$861K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$19.3M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$35.13M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$29.62M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$28.32M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$19.29M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$9.18M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$6.78M
Current Liabilities Q3 2025 · Sep 30, 2025 $116.2M
Current Liabilities Q3 2025 · Dec 31, 2024 $100.44M
Total Liabilities Q3 2025 · Sep 30, 2025 $371.05M
Total Liabilities Q3 2025 · Dec 31, 2024 $352.68M
Current Assets Q3 2025 · Sep 30, 2025 $224.02M
Current Assets Q3 2025 · Dec 31, 2024 $167.66M
Total Assets Q3 2025 · Sep 30, 2025 $370.19M
Total Assets Q3 2025 · Dec 31, 2024 $323.06M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.34
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2024 −$0.11
Eps Basic Q3 2025 · Sep 30, 2024 −$0.34
Sga Expense Q3 2025 · Sep 30, 2025 $46.46M
Sga Expense Q3 2025 · Sep 30, 2025 $134.87M
Sga Expense Q3 2025 · Sep 30, 2024 $44.97M
Sga Expense Q3 2025 · Sep 30, 2024 $123.34M
Rd Expense Q3 2025 · Sep 30, 2025 $7.48M
Rd Expense Q3 2025 · Sep 30, 2025 $23.29M
Rd Expense Q3 2025 · Sep 30, 2024 $5.89M
Rd Expense Q3 2025 · Sep 30, 2024 $19.47M
Net Income Q3 2025 · Sep 30, 2025 $621K
Net Income Q3 2025 · Sep 30, 2025 −$10.53M
Net Income Q3 2025 · Jun 30, 2025 −$1.93M
Net Income Q3 2025 · Mar 31, 2025 −$9.22M
Net Income Q3 2025 · Sep 30, 2024 −$15.74M
Net Income Q3 2025 · Sep 30, 2024 −$49.72M
Net Income Q3 2025 · Jun 30, 2024 −$15.01M
Net Income Q3 2025 · Mar 31, 2024 −$18.98M
Operating Income Q3 2025 · Sep 30, 2025 $6.73M
Operating Income Q3 2025 · Sep 30, 2025 $8.12M
Operating Income Q3 2025 · Sep 30, 2024 −$12.89M
Operating Income Q3 2025 · Sep 30, 2024 −$35.33M
Revenue Q3 2025 · Sep 30, 2025 $74.38M
Revenue Q3 2025 · Sep 30, 2025 $206.04M
Revenue Q3 2025 · Sep 30, 2024 $54.27M
Revenue Q3 2025 · Sep 30, 2024 $142.97M